LINDEN RESEARCH UNITED KINGDOM LTD

Business Description

LINDEN RESEARCH UNITED KINGDOM LTD is registered as a business entity on 24 March 2008 (16.7 years ago) structured as a Foreign Company Registered In Singapore (Foreign Company) with 3 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) T08FC7180H. The business official address is located at 8 Cross Street #11-00, Pwc Building, Singapore 48424 with main trading activity as Research And Development in the primary industry of 72102: Research And Experimental Development On Electronics (excluding Medical Science) using Singapore Dollars - SGD as its default trading currency. The business name remains unchanged since inception. The business annual account filing date falls on 24 March and is no longer operational with the status of 'na'. The business paid up share capital is GBP 0, with preference share capital of GBP 0, and other share capital at GBP 0.

In the past 365 days, LINDEN RESEARCH UNITED KINGDOM LTD has received a total of Login to view reported payment review(s). 0 were rated Good and Login to view were rated Poor. Therefore no payment reviews were made recently. The aggregated good payment amount is equivalent to USD 0, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "A" suggest a healthy payment culture where settlement with stakeholders is always prioritised. Since the business is registered as a foreign company, it is the offshore branch of a parent orgnisation and more research should to be done to understand its local presence. The lack of an appointed auditor indicates that the business is small sized as it did not meet the regulatory requirements of revenue or assets exceeding SGD 10 million, or has more than 50 employees in the previous two fiscal years.

LINDEN RESEARCH UNITED KINGDOM LTD is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023